EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes

Elaine C Chen, Pavlo Gilchuk, Seth J Zost, Philipp A Ilinykh, Elad Binshtein, Kai Huang, Luke Myers, Stefano Bonissone, Samuel Day, Chandrahaas R Kona, Andrew Trivette, Joseph X Reidy und 12 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Elaine C Chen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Ebolavirus, Hemorrhagic Fever, Ebola. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Merck KGaA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EbolavirusHemorrhagic Fever, EbolaHumansAnimalsMiceAntibodies, NeutralizingAntibodies, ViralAntibody FormationPrevalenceGlycoproteins

Stichwörter der Autor:innen

CP: ImmunologyEbolaadaptive immunityantibodieshumanmonoclonalrepertoire

Substanzen

Antibodies, NeutralizingAntibodies, ViralGlycoproteins

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Galveston National Laboratory, Galveston, TX 77550, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Abterra Biosciences, San Diego, CA 92109, USA.
  • Integral Molecular, Inc., Philadelphia, PA 19104, USA.
  • Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • Merck KGaA

Zitieren

APA

Chen, E. C., Gilchuk, P., Zost, S. J., Ilinykh, P. A., Binshtein, E., Huang, K., Myers, L., Bonissone, S., Day, S., Kona, C. R., Trivette, A., Reidy, J. X., Sutton, R. E., Gainza, C., Diaz, S., Williams, J. K., Selverian, C. N., Davidson, E., Saphire, E. O., …, & Crowe, J. E. (2023). Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112370

Vancouver

Chen EC, Gilchuk P, Zost SJ, Ilinykh PA, Binshtein E, Huang K, et al. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112370

BibTeX
@article{Chen2023,
  author = {Chen, Elaine C and Gilchuk, Pavlo and Zost, Seth J and Ilinykh, Philipp A and Binshtein, Elad and Huang, Kai and Myers, Luke and Bonissone, Stefano and Day, Samuel and Kona, Chandrahaas R and Trivette, Andrew and Reidy, Joseph X and Sutton, Rachel E and Gainza, Christopher and Diaz, Summer and Williams, Jazmean K and Selverian, Christopher N and Davidson, Edgar and Saphire, Erica Ollmann and Doranz, Benjamin J and Castellana, Natalie and Bukreyev, Alexander and Carnahan, Robert H and Crowe, James E},
  title = {Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112370}
}
Kostenlos starten →